James F. Cummings's most recent trade in Vaxart Inc was a trade of 3,292 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on March 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.42 per share. | 28 Mar 2025 | 3,292 | 745,757 (1%) | 0% | 0.4 | 1,387 | Common Stock |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 610,000 | 610,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 406,000 | 749,049 (1%) | 0% | 0 | Common Stock | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. | 02 Feb 2025 | 7,964 | 318,837 (0%) | 0% | 0.7 | 5,414 | Common Stock |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 28 Mar 2024 | 3,292 | 326,801 (0%) | 0% | 1.3 | 4,280 | Common Stock |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 90,000 | 330,093 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. | 08 Dec 2023 | 31,409 | 248,058 (0%) | 0% | 0.7 | 22,300 | Common Stock |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 08 Dec 2023 | 7,965 | 240,093 (0%) | 0% | 1.2 | 9,558 | Common Stock |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 28 Mar 2023 | 6,772 | 343,049 (0%) | 0% | 0.6 | 3,861 | Common Stock |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 28 Mar 2023 | 3,267 | 349,821 (0%) | 0% | 0.8 | 2,451 | Common Stock |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 205,000 | 205,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 90,000 | 238,100 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 59,350 | 148,100 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 45,000 | 88,750 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 262,500 | 262,500 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | James F. Cummings | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 43,750 | 43,750 (0%) | 0% | 0 | Common Stock |